Health Care: Drugs

Echo Therapeutics Inc (ECTE: NASDAQ)

$1.66 n/a | n/a%
06/24/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 0.00 57.32K 27.60K 5.12K
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 0.00 57.32K 27.60K 5.12K
Selling, General, and Administrative Expenses 4.33M 7.42M 8.37M 6.37M
Research & Development 2.79M 4.96M 11.30M 8.67M
Operating Income before D & A (EBITDA) -7.11M -12.32M -19.64M -15.04M
Depreciation & Amortization 521.86K 3.94M 4.24M 689.12K
Interest Income 0.00 978.00 3.05K 5.47K
Other Income - Net -4.92M 911.77K 4.47M 3.66M
Special Income / Charges -9.62M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -22.18M -15.35M -19.41M -12.06M
Interest Expense 15.34K 3.55M 3.90M 959.86K
Pre-Tax Income -22.19M -18.90M -23.31M -13.02M
Income Taxes 3.42K 4.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -22.20M -14.96M -19.07M -12.33M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -22.20M -14.96M -19.07M -12.33M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -22.20M -14.96M -19.07M -12.33M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-12.57M -14.96M -19.07M -12.33M
Preferred Dividends
Net Income Available To Common -22.20M -15.31M -19.44M -12.33M
Basic EPS from Continuing Ops. -1.98 -1.24 -2.33 -3.12
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.98 -1.24 -2.33 -3.12
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.02
Basic EPS, Total -1.98 -1.24 -2.33 -3.10
Basic Normalized Net Income/Share -1.12 -1.24 -2.33 -3.12
EPS fr Continuing Ops. -1.98 -1.24 -2.33 -3.12
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.98 -1.24 -2.33 -3.12
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.02
EPS, Total -1.98 -1.24 -2.33 -3.10
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.12 -1.24 -2.33 -3.12
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ECTE

Latest ECTE Headlines from TheStreet

More Financial News for ECTE

Press Releases for ECTE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter